Biocytogen Pharmaceu...
SEHK:2315
HK$ 58,45
+ HK$4,65 (8,64%)
58,45 HK$
+HK$4,65 (8,64%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

HK$0,32
Earnings Per Share
HK$3,63
Revenue Per Share
100,00%
Gross Margin %
HK$41,24 B
Market Cap
HK$0,21 B
Long-Term Debt
Earnings Per Share
HK$0,32
Revenue Per Share
HK$3,63
Gross Margin %
100,00%
Market Cap
HK$41,24 B
Long-Term Debt
HK$0,21 B

Financials

Year Year 2025 2024 2023
EPS Earnings Per Share HK$0,32 HK$0,09 HK$-0,96
Earnings Earnings HK$135,24M HK$35,95M HK$-383,42M
RPS Revenue Per Share HK$3,63 HK$2,61 HK$1,79
Revenue Revenue HK$1,53B HK$1,04B HK$716,91M
OCF Operating Cash Flow HK$491,86M HK$0,00M HK$-76,65M
FCF Free Cash Flow HK$0,00M HK$0,00M HK$0,00M
OM Operating Margin 13,68% 15,32% -40,66%
GM % Gross Margin % 100,00% 79,12% 71,27%
FCFS Free Cash Flow Per Share HK$0,00 HK$0,47 HK$-0,51
LT Debt Long-Term Debt N/A HK$206,27M N/A
Sha. Stocks 422,63M 399,4M 399,4M
×